These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 17659816)
21. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis. Palmer MV; Thacker TC; Waters WR Zoonoses Public Health; 2009 Jun; 56(5):243-51. PubMed ID: 19175569 [TBL] [Abstract][Full Text] [Related]
22. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Ritz N; Tebruegge M; Connell TG; Sievers A; Robins-Browne R; Curtis N Antimicrob Agents Chemother; 2009 Jan; 53(1):316-8. PubMed ID: 18955515 [TBL] [Abstract][Full Text] [Related]
23. Comment on Hesseling, et al. "The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children" [Vaccine 25 (2006) 14-18]. Taştan Y Vaccine; 2007 Jun; 25(23):4513. PubMed ID: 17434241 [No Abstract] [Full Text] [Related]
24. Development of a Mycobacterium bovis intranasal challenge model in mice. Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980 [TBL] [Abstract][Full Text] [Related]
25. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection. Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343 [TBL] [Abstract][Full Text] [Related]
26. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate. Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043 [TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of postvaccinal complications after administration of BCG vaccine. (Methodical recommendations No. 99/219]. Health Ministry of the Russian Federation, Moscow. Moscow 2000 Probl Tuberk; 2002; (6):53-6. PubMed ID: 12227058 [No Abstract] [Full Text] [Related]
28. BCG vaccination: a long-lasting protection against tuberculosis? Hernández-Garduño E Lancet Infect Dis; 2016 Apr; 16(4):408. PubMed ID: 27036343 [No Abstract] [Full Text] [Related]
32. BCG vaccine. WHO position paper. World Health Organization Wkly Epidemiol Rec; 2004 Jan; 79(4):27-38. PubMed ID: 14768305 [No Abstract] [Full Text] [Related]
33. The challenges of an HIV vaccine enterprise. Zinkernagel RM Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14988536 [No Abstract] [Full Text] [Related]
34. [L-forms of BCG Mycobacteria and their capacity to induce morphological reactions inherent in the BCG vaccine]. Shmelev NA; Dorozhkova IR; Zemskova ZS Probl Tuberk; 1974; (1):62-70. PubMed ID: 4617227 [No Abstract] [Full Text] [Related]
35. BCG vaccination in children born to HIV-positive mothers. Matondo P Lancet; 1992 Sep; 340(8822):800. PubMed ID: 1356222 [No Abstract] [Full Text] [Related]
36. A plea for the use of BCG vaccine against tuberculosis in the United States. Rosenthal SR Med Times; 1978 Jul; 106(7):2d (88)-(88)-7d. PubMed ID: 353438 [No Abstract] [Full Text] [Related]